Latest filing published 11 Dec 2017 for PharMerica CORP.
Gregory S. Weishar discloses dealings in PharMerica Corp to SEC (Form 4). The record holds 16 filings, for trades running from 10 February 2016 to 7 December 2017.
Every open-market trade on record is a sale: 2 sales worth €12.9M. Outside the open market, there are 10 share grants and 2 option exercises. In 2017 alone, the filings show no purchases and 2 sales.
The newest entry dates from 11 December 2017: a transaction, in PharMerica Corp. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 4 days. For comparison, the SEC allows two business days to file a Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
16 of 16 declarations